These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 19128200)

  • 41. Dopamine D3 receptor ligands show place conditioning effect but do not influence cocaine-induced place preference.
    Gyertyán I; Gál K
    Neuroreport; 2003 Jan; 14(1):93-8. PubMed ID: 12544838
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current drug treatments targeting dopamine D3 receptor.
    Leggio GM; Bucolo C; Platania CB; Salomone S; Drago F
    Pharmacol Ther; 2016 Sep; 165():164-77. PubMed ID: 27343365
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of a D3 receptor antagonist on context-induced reinstatement of nicotine seeking.
    Sabioni P; Di Ciano P; Le Foll B
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():149-54. PubMed ID: 26279138
    [TBL] [Abstract][Full Text] [Related]  

  • 44. GABA(B) receptor agonists for the treatment of drug addiction: a review of recent findings.
    Cousins MS; Roberts DC; de Wit H
    Drug Alcohol Depend; 2002 Feb; 65(3):209-20. PubMed ID: 11841892
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeting the dopamine D3 receptor: an overview of drug design strategies.
    Cortés A; Moreno E; Rodríguez-Ruiz M; Canela EI; Casadó V
    Expert Opin Drug Discov; 2016 Jul; 11(7):641-64. PubMed ID: 27135354
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute administration of SB-277011A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats: role of dopamine D3 receptors.
    Gilbert JG; Newman AH; Gardner EL; Ashby CR; Heidbreder CA; Pak AC; Peng XQ; Xi ZX
    Synapse; 2005 Jul; 57(1):17-28. PubMed ID: 15858839
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Imperial College Cambridge Manchester (ICCAM) platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part A: Study description.
    Paterson LM; Flechais RS; Murphy A; Reed LJ; Abbott S; Boyapati V; Elliott R; Erritzoe D; Ersche KD; Faluyi Y; Faravelli L; Fernandez-Egea E; Kalk NJ; Kuchibatla SS; McGonigle J; Metastasio A; Mick I; Nestor L; Orban C; Passetti F; Rabiner EA; Smith DG; Suckling J; Tait R; Taylor EM; Waldman AD; Robbins TW; Deakin JF; Nutt DJ; Lingford-Hughes AR;
    J Psychopharmacol; 2015 Sep; 29(9):943-60. PubMed ID: 26246443
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recent advances in the development of dopamine D3 receptor antagonists: a medicinal chemistry perspective.
    Micheli F
    ChemMedChem; 2011 Jul; 6(7):1152-62. PubMed ID: 21425240
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhanced apomorphine sensitivity and increased binding of dopamine D2 receptors in nucleus accumbens in prepubertal rats after neonatal blockade of the dopamine D3 receptors by (+)-S14297.
    Flores-Tochihuitl J; Vargas G; Morales-Medina JC; Rivera G; De La Cruz F; Zamudio S; Flores G
    Synapse; 2008 Jan; 62(1):40-9. PubMed ID: 17957737
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of the dopamine D3 receptor in reactivity to cocaine-associated cues in mice.
    Le Foll B; Francès H; Diaz J; Schwartz JC; Sokoloff P
    Eur J Neurosci; 2002 Jun; 15(12):2016-26. PubMed ID: 12099907
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of dopamine D(3) receptors in antipsychotic activity and cognitive functions.
    Gross G; Drescher K
    Handb Exp Pharmacol; 2012; (213):167-210. PubMed ID: 23027416
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of peripheral and central sodium channels in mediating brain temperature fluctuations induced by intravenous cocaine.
    Kiyatkin EA; Brown PL
    Brain Res; 2006 Oct; 1117(1):38-53. PubMed ID: 16956595
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Caffeine increases striatal dopamine D2/D3 receptor availability in the human brain.
    Volkow ND; Wang GJ; Logan J; Alexoff D; Fowler JS; Thanos PK; Wong C; Casado V; Ferre S; Tomasi D
    Transl Psychiatry; 2015 Apr; 5(4):e549. PubMed ID: 25871974
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Occupancy of brain dopamine D3 receptors and drug craving: a translational approach.
    Mugnaini M; Iavarone L; Cavallini P; Griffante C; Oliosi B; Savoia C; Beaver J; Rabiner EA; Micheli F; Heidbreder C; Andorn A; Merlo Pich E; Bani M
    Neuropsychopharmacology; 2013 Jan; 38(2):302-12. PubMed ID: 22968817
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 1,2,4-Triazolyl azabicyclo[3.1.0]hexanes: a new series of potent and selective dopamine D(3) receptor antagonists.
    Micheli F; Arista L; Bonanomi G; Blaney FE; Braggio S; Capelli AM; Checchia A; Damiani F; Di-Fabio R; Fontana S; Gentile G; Griffante C; Hamprecht D; Marchioro C; Mugnaini M; Piner J; Ratti E; Tedesco G; Tarsi L; Terreni S; Worby A; Ashby CR; Heidbreder C
    J Med Chem; 2010 Jan; 53(1):374-91. PubMed ID: 19891474
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An endogenous neuroprotectant substance, 1-methyl-1,2,3,4-tetrahydroisoquinoline (1MeTIQ), prevents the behavioral and neurochemical effects of cocaine reinstatement in drug-dependent rats.
    Antkiewicz-Michaluk L; Filip M; Michaluk J; Romańska I; Przegaliński E; Vetulani J
    J Neural Transm (Vienna); 2007 Mar; 114(3):307-17. PubMed ID: 16897599
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuronal Dopamine D3 Receptors: Translational Implications for Preclinical Research and CNS Disorders.
    Kiss B; Laszlovszky I; Krámos B; Visegrády A; Bobok A; Lévay G; Lendvai B; Román V
    Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33466844
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dopaminergic modulation of risk-based decision making.
    St Onge JR; Floresco SB
    Neuropsychopharmacology; 2009 Feb; 34(3):681-97. PubMed ID: 18668030
    [TBL] [Abstract][Full Text] [Related]  

  • 59. There and back again: a tale of norepinephrine and drug addiction.
    Weinshenker D; Schroeder JP
    Neuropsychopharmacology; 2007 Jul; 32(7):1433-51. PubMed ID: 17164822
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Positron emission tomography molecular imaging of dopaminergic system in drug addiction.
    Hou H; Tian M; Zhang H
    Anat Rec (Hoboken); 2012 May; 295(5):722-33. PubMed ID: 22467195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.